EPIC TIGER - Epigenetic control of virus transmission by the Asian tiger mosquito
- Funded by Netherlands Organisation for Health Research and Development (ZonMW)
- Total publications:0 publications
Grant number: 4.51001E+12
Grant search
Key facts
Disease
Unspecified, UnspecifiedStart & end year
20242025Known Financial Commitments (USD)
$0Funder
Netherlands Organisation for Health Research and Development (ZonMW)Principal Investigator
dr. P MiesenResearch Location
NetherlandsLead Research Institution
Radboud Universitair Medisch CentrumResearch Priority Alignment
N/A
Research Category
Animal and environmental research and research on diseases vectors
Research Subcategory
Vector control strategies
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
The Asian tiger mosquito Aedes Albopictus is an invasive species that transfers viruses such as the dengue and the Chikungunya virus. Before virustansmission takes place, these viruses must first multiply in the mosquito. Processes that prevent the virus reproduction in the MUG can therefore inhibit the virustansmission. However, the operating mechanisms of these types of processes are still largely unknown. In Epic Tiger, the researchers study whether epigenetic regulation plays a role in the defense against viruses in the mosquito. Proteins involved in epigenetic processes are best known as promising targets for cancer therapy in humans. As a result, an extensive selection of chemicals is available that inhibit these factors. In Epic Tiger, the scientists investigate whether these epigenetic inhibitors can prevent virus reproduction in the mosquito and can be used as a new strategy to block virus spreads by mosquitoes.